These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 25907173)
1. A case of lacosamide-induced hepatotoxicity. Sunwoo JS; Byun JI; Lee SK Int J Clin Pharmacol Ther; 2015 Jun; 53(6):471-3. PubMed ID: 25907173 [TBL] [Abstract][Full Text] [Related]
2. Early monitoring for detection of antituberculous drug-induced hepatotoxicity. Lee CM; Lee SS; Lee JM; Cho HC; Kim WS; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ Korean J Intern Med; 2016 Jan; 31(1):65-72. PubMed ID: 26767859 [TBL] [Abstract][Full Text] [Related]
3. Clinical stabilisation with lacosamide of mood disorder comorbid with PTSD and fronto-temporal epilepsy. Cuomo I; Kotzalidis GD; De Filippis S Acta Biomed; 2017 Aug; 88(2):185-189. PubMed ID: 28845834 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy. Pasha I; Kamate M; Didagi SK Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613 [TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial. Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy. Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195 [TBL] [Abstract][Full Text] [Related]
8. First case of lacosamide-induced psychosis. Chatzistefanidis D; Karvouni E; Kyritsis AP; Markoula S Clin Neuropharmacol; 2013; 36(1):27-8. PubMed ID: 23334072 [TBL] [Abstract][Full Text] [Related]